[Methodology of phase II study].
Phase II trial is a clinical study in order to investigate the usefulness of new antitumor agents. This review describes the study methodology including purpose eligible conditions of patients, signal tumors, prognostic, factors relating to efficacy and criterion to assess responses.
D000970:Antineoplastic Agents; D004341:Drug Evaluation / Q000379:methods* / Q000592:standards; D006801:Humans
D000970:Antineoplastic Agents